Nucleophosmin gene mutations promote NIH3T3 cell migration and invasion through CXCR4 and MMPs

Experimental and Molecular Pathology

Volumn 90, Issue 1, 2011, Pages 38-44

  Shao, Hui Yuan ^a   Miao, Zong Yu ^a   Hui Chen, ^a   Qin, Feng Xian ^a   Chen, Xian Chun ^a   Tan, Shi ^a   Zhang, Hui Juan ^a   Wang, Li ^a   Gao, Yu Jie ^a   Yang, Zai Lin ^b   Zhang, Ling ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CXCR4; Invasion; Migration; MMPs; Mutation; Nucleophosmin

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GELATINASE A; GELATINASE B; NUCLEOPLASMIN;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC TRANSFECTION; IN VITRO STUDY; LEUKEMOGENESIS; MOUSE; NONHUMAN; PLASMID;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; MATRIX METALLOPROTEINASES; MICE; MUTATION; NEOPLASM INVASIVENESS; NIH 3T3 CELLS; NUCLEAR PROTEINS; PLASMIDS; RECEPTORS, CXCR4; TRANSFECTION;

EID: 78650121790     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.11.009     Document Type: Article

References (28)

1. Amin M.A., Matsunaga S., Uchiyama S., Fukui K. Depletion of nucleophosmin leads to distortion of nucleolar and nuclear structures in HeLa cells. Biochem. J. 2008, 415:345-351.
2. Bonetti P., Davoli T., Sironi C., Amati B., Pelicci P.G., Colombo E. Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7 gamma. J. Cell Biol. 2008, 182:19-26.
3. Burger J.A., Kipps T.J. CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
4. Burger J.A., Peled A. CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 2009, 23:43-52.
5. Castellano G., Malaponte G., Mazzarino M.C., Figini M., Marchese F., Gangemi P., Travali S., Stivala F., Canevari S., Libra M. Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression. Clin. Cancer Res. 2008, 14:7470-7480.
6. Cheng K., Grisendi S., Clohessy J.G., Majid S., Bernardi R., Sportoletti P., Pandolfi P.P. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence. Oncogene 2007, 26:7391-7400.
7. Colombo E., Martinelli P., Zamponi R., Shing D.C., Bonetti P., Luzi L., Volorio S., Bernard L., Pruneri G., Alcalay M., Pelicci P.G. Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant. Cancer Res. 2006, 66:3044-3050.
8. Egeblad M., Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2002, 2:161-174.
9. Falini B., Mecucci C., Tiacci E., Alcalay M., Rosati R., Pasqualucci L., La Starza R., Diverio D., Colombo E., Santucci A., Bigerna B., Pacini R., Pucciarini A., Liso A., Vignetti M., Fazi P., Meani N., Pettirossi V., Saglio G., Mandelli F., Lo-Coco F., Pelicci P.G., Martelli M.F. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N. Engl. J. Med. 2005, 352:254-266.
10. Gurumurthy M., Tan C.H., Ng R., Zeiger L., Lau J., Lee J., Dey A., Philp R., Li Q., Lim T.M., Price D.H., Lane D.P., Chao S.H. Nucleophosmin interacts with HEXIM1 and regulates RNA polymerase II transcription. J. Mol. Biol. 2008, 378:302-317.
11. Hatfield K.J., Hovland R., Øyan A.M., Kalland K.H., Ryningen A., Gjertsen B.T., Bruserud Ø. Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels. Leukemia 2008, 22:287-293.
12. Ho M.L., Chen P.N., Chu S.C., Kuo D.Y., Kuo W.H., Chen J.Y., Hsieh Y.S. Peonidin 3-glucoside inhibits lung cancer metastasis by downregulation of proteinases activities and MAPK pathway. Nutr. Cancer 2010, 62:505-516.
13. Karroum A., Mirshahi P., Benabbou N., Faussat A.M., Soria J., Therwath A., Mirshahi M., Hatmi M. Matrix metalloproteinase-9 is required for tubular network formation and migration of resistant breast cancer cells MCF-7 through PKC and ERK1/2 signalling pathways. Cancer Lett. 2010, 295:242-251.
14. Kim S.C., Magesh V., Jeong S.J., Lee H.J., Ahn K.S., Lee H.J., Lee E.O., Kim S.H., Lee M.H., Kim J.H., Kim S.H. Ethanol extract of Ocimum sanctum exerts anti-metastatic activity through inactivation of matrix metalloproteinase-9 and enhancement of anti-oxidant enzymes. Food Chem. Toxicol. 2010, 48:1478-1482.
15. Lubbe W.J., Zuzga D.S., Zhou Z., Fu W., Pelta-Heller J., Muschel R.J., Waldman S.A., Pitari G.M. Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res. 2009, 69:3529-3536.
16. Martins S.J., Takagaki T.Y., Silva A.G., Gallo C.P., Silva F.B., Capelozzi V.L. Prognostic relevance of TTF-1 and MMP-9 expression in advanced lung adenocarcinoma. Lung Cancer 2009, 64:105-109.
17. Meani N., Alcalay M. Role of nucleophosmin in acute myeloid leukemia. Expert Rev. Anticancer Ther. 2009, 9:1283-1294.
18. O'Grady A., Dunne C., O'Kelly P., Murphy G.M., Leader M., Kay E. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. Histopathology 2007, 51:793-804.
19. Paupert J., Mansat-De Mas V., Demur C., Salles B., Muller C. Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features. Cell Cycle 2008, 7:1047-1053.
20. Rau R., Brown P. Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity. Hematol. Oncol. 2009, 27:171-181.
21. Redondo-Muñoz J., Escobar-Díaz E., Samaniego R., Terol M.J., García-Marco J.A., García-Pardo A. MMP-9 in B-cell chronic lymphocytic leukemia is up-regulated by alpha4beta1 integrin or CXCR4 engagement via distinct signaling pathways, localizes to podosomes, and is involved in cell invasion and migration. Blood 2006, 108:3143-3151.
22. Redondo-Muñoz J., José Terol M., García-Marco J.A., García-Pardo A. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration. Blood 2008, 111:383-386.
23. Schlenk R.F., Döhner K., Krauter J., Fröhling S., Corbacioglu A., Bullinger L., Habdank M., Späth D., Morgan M., Benner A., Schlegelberger B., Heil G., Ganser A., Döhner H. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N. Engl. J. Med. 2008, 358:1909-1918.
24. Thiede C., Koch S., Creutzig E., Steudel C., Illmer T., Schaich M., Ehninger G. Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML). Blood 2006, 107:4011-4020.
25. Vardiman J.W., Thiele J., Arber D.A., Brunning R.D., Borowitz M.J., Porwit A., Harris N.L., Le Beau M.M., Hellström-Lindberg E., Tefferi A., Bloomfield C.D. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 2009, 114:937-951.
26. Wang Z., Li Y., Banerjee S., Kong D., Ahmad A., Nogueira V., Hay N., Sarkar F.H. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J. Cell. Biochem. 2010, 109:726-736.
27. Wanzel M., Russ A.C., Kleine-Kohlbrecher D., Colombo E., Pelicci P.G., Eilers M. A ribosomal protein L23-nucleophosmin circuit coordinates Mizl function with cell growth. Nat. Cell Biol. 2008, 10:1051-1061.
28. Zhang W., Navenot J.M., Frilot N.M., Fujii N., Peiper S.C. Association of nucleophosmin negatively regulates CXCR4-mediated G protein activation and chemotaxis. Mol. Pharmacol. 2007, 72:1310-1321.